Australian researchers have uncovered a critical mechanism driving the growth and spread of glioblastoma—one of the most aggressive and lethal forms of brain cancer—potentially paving the way for more effective treatments. In a study led by Adelaide University scientists from the Centre for Cancer Biology (CCB), researchers have identified a previously unrecognized role for a protein called CD47 in promoting tumor progression, independent of its known function in helping cancer evade the immune system. The work appears in Proceedings of the National Academy of Sciences.
This article was originally published on MedicalXpress.com
